Chacko Jacob — SEC Form 4 filings
SEC reporting owner CIK 1608936. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-08 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 388,034 shares, $4,509,321 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 125,000 shares @ $10.80 ($1,349,938) in Oric Pharmaceuticals, Inc., filed 2025-09-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | PRESIDENT AND CEO, Director | 9 | — | 9 legs · 388,034 sh · $4,509,321 | 12 |
| 4D Molecular Therapeutics, Inc. (FDMT) | Director | 3 | — | — | 3 |
Form 4 filings — Chacko Jacob
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 83,666 @ $0 · Sale (S): 33,374 @ $9.06 · Option exercise (M): 22,000 (derivative) @ $0 · Option exercise (M): 28,333 (derivative) @ $0 · Option exercise (M): 33,333 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 37,461 @ $12.32 | EDGAR |
| 2025-10-02 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 34,538 @ $12.01 · Sale (S): 53,001 @ $12.05 | EDGAR |
| 2025-09-24 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 125,000 @ $10.80 | EDGAR |
| 2025-06-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Option exercise (M): 67,000 @ $0 · Sale (S): 24,660 @ $8.28 · Option exercise (M): 16,667 (derivative) @ $0 · Option exercise (M): 22,000 (derivative) @ $0 · Option exercise (M): 28,333 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 40,000 @ $16.21 | EDGAR |
| 2024-02-08 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Sale (S): 13,958 @ $12.12 · Sale (S): 26,042 @ $12.29 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1608936 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →